Black Bird Biotech Inc BBBT
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if BBBT is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.00 / $0.00
- Market Cap
- $357,086.03
- Volume/Avg
- 2.1 Mil / 10.7 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 9.52
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Black Bird Biotech Inc is a licensed grower of industrial hemp under the Montana Hemp Pilot Program. In addition, it is the distributor in the U. S. and Canada for MiteXstream, an EPA-registered plant-based biopesticide effective in the eradication of spider mites, a pest that destroys crops, especially cannabis, hops, coffee, and house plants, as well as molds and mildew. Its products include MiteXstream Biopesticide, Grizzly Creek Naturals, and Black Bird American Hemp.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- —
- Total Number of Employees
- 4
Valuation
|
Metric
|
BBBT
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 9.52 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
BBBT
|
|---|---|
Quick Ratio | 0.02 |
Current Ratio | 0.09 |
Interest Coverage | −0.60 |
Quick Ratio
BBBT
Profitability
|
Metric
|
BBBT
|
|---|---|
Return on Assets (Normalized) | −533.72% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
BBBT
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Lrkmmmwsy | Fgl | $70.0 Bil | |
MKKGY
| Merck KGaA ADR | Ffqcqdvv | Ymxjgn | $68.4 Bil | |
HLN
| Haleon PLC ADR | Nsxjsbr | Sdq | $37.0 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Qkdtkpxnf | Zqky | $14.5 Bil | |
VTRS
| Viatris Inc | Yvzrgtmz | Rsxr | $13.4 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Xtmzvkb | Ylcn | $12.0 Bil | |
CTLT
| Catalent Inc | Qpntdldz | Dttrqwm | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Wbnydxc | Gxyl | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Gpfzxxbgf | Ctyp | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Thqryqqv | Nbtsjg | $3.5 Bil |